TransMedics Group (TMDX) Stock Price, Quote, News & History | Benzinga

TransMedics Group Inc (TMDX) Stock Price, Quote, News & History

TMDXNASDAQ

Trade with Public

Trade with Public

$93.99

0.390.42%

Last update: Aug 25, 12:41 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$93.62

Close

-

Volume / Avg.

167.24K / 1.03M

Day Range

$91.50 - $94.33

52 Wk Range

60.11 - 156.00

Market Cap

$3.25B

P/E Ratio

24.25

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

34.63%

Days to Cover

9.5

Recent TransMedics Group, Inc. News

SpaceX, Teradata, Pinterest And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

U.S. stock futures mixed, Dow up 100 points. SpaceX stock falls 10.3% after reporting strong Q2 revenue but a loss. Other stocks also decline.

Avi Kapoor

Upstart Posts Downbeat Q1 Earnings, Joins Wolfspeed, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures up, Dow gains 200 points. Upstart (UPST) falls 11.8% on weak Q1 EPS and FY26 sales guidance. Other stocks also down in pre-market.

Avi Kapoor

Why Veeco Instruments Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket

Veeco Instruments Inc (NASDAQ: VECO) rose in pre-market trading after reporting Q1 results and affirming FY26 sales guidance with midpoint above estimates. Other gainers include EZGO, EVC, GCTK, AVTX, OCG, COMP, ALIT, TBH, and SMCI, while losers include ATOM, NWGL, and APUS.

Avi Kapoor

Bears Pounce On Avis Budget, Lucid, MARA — Short Interest In These 10 Stocks Soars Above 40%

Choice Hotels, Avis Budget and Lucid stock all have short-interest above 50% of their free floats.

Erica Kollmann

Why Axon Enterprise Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

145.93M

Investing Cash Flow (TTM)

-66.89M

Financing Cash Flow (TTM)

11.47M

Free Cash Flow (TTM)

79.04M

Capital Expenditure (TTM)

-66.89M

Net Change in Cash (TTM)

90.51M

Analyst Trends and Forecast

4

May

1

Jun

2

1

Jul

2

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$3.64B

PE Ratio (TTM)

24.25

PE Ratio (FWD)

64.10

PEG Ratio (TTM)

1.28

PS Ratio (TTM)

5.38

PB Ratio (TTM)

6.26

Earnings Yield % (TTM)

4.12%

Earnings Yield % (FWD)

1.56%

EV / EBITDA (TTM)

27.96

Price / EBITDA (TTM)

27.62

Price / Free Cash Flow (TTM)

45.50

Book Value / Share

$14.94

Company Debt

Total Debt

$514.00M

LT Debt

$494.00M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$472.68M

Debt to Equity

1.67

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$93.62

Close

-

Volume / Avg.

167.24K / 1.03M

Day Range

$91.50 - $94.33

52 Wk Range

60.11 - 156.00

Market Cap

$3.25B

P/E Ratio

24.25

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

34.63%

Days to Cover

9.5

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy TransMedics Group (TMDX) stock?

A

You can purchase shares of TransMedics Group (NASDAQ:TMDX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are TransMedics Group (TMDX) competitors?

A

Other companies in TransMedics Group’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT) and Boston Scientific Corp (NYSE:BSX).

Q

What is the forecast, or price target, for TransMedics Group (TMDX) stock?

A

TransMedics Group has a consensus price target of $113.22.

Q

What is the current price for TransMedics Group (TMDX)?

A

The stock price for TransMedics Group (NASDAQ: TMDX) is $93.99 last updated August 25, 2026 at 12:41 PM EDT.

Q

Does TransMedics Group (TMDX) pay a dividend?

A

There are no upcoming dividends for TransMedics Group.

Q

When is TransMedics Group (NASDAQ:TMDX) reporting earnings?

A

TransMedics Group does not have any upcoming earnings scheduled.

Q

Is TransMedics Group (TMDX) going to split?

A

There is no upcoming split for TransMedics Group.

Q

What sector and industry does TransMedics Group (TMDX) operate in?

A

TransMedics Group is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.